Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
Ophthalmic Physiol Opt
.
2022 Nov;42(6):1412-1413.
doi: 10.1111/opo.13052.
Epub 2022 Sep 16.
Author
Convergence Insufficiency Treatment Trial (CITT) Investigator Group and the Convergence Insufficiency Treatment Trial-Attention and Reading Trial (CITT-ART) Investigator Group
PMID:
36111644
PMCID:
PMC10578959
DOI:
10.1111/opo.13052
No abstract available
Publication types
Published Erratum
Grants and funding
U10 EY022594/EY/NEI NIH HHS/United States
U10 EY014709/EY/NEI NIH HHS/United States
U10 EY022592/EY/NEI NIH HHS/United States
U10 EY022586/EY/NEI NIH HHS/United States
U10 EY022601/EY/NEI NIH HHS/United States
U10 EY022591/EY/NEI NIH HHS/United States
U10 EY022596/EY/NEI NIH HHS/United States
U10 EY014710/EY/NEI NIH HHS/United States
U10 EY014716/EY/NEI NIH HHS/United States
U10 EY014659/EY/NEI NIH HHS/United States
U10 EY014712/EY/NEI NIH HHS/United States
U10 EY022587/EY/NEI NIH HHS/United States
U10 EY014676/EY/NEI NIH HHS/United States
U10 EY014706/EY/NEI NIH HHS/United States
U10 EY014713/EY/NEI NIH HHS/United States
U10 EY022599/EY/NEI NIH HHS/United States
U10 EY014715/EY/NEI NIH HHS/United States
U10 EY022595/EY/NEI NIH HHS/United States
U10 EY022600/EY/NEI NIH HHS/United States